These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8857460)

  • 21. Alternative testing proposed.
    Fogarty MM
    ASHA; 1991 Sep; 33(9):65. PubMed ID: 1750856
    [No Abstract]   [Full Text] [Related]  

  • 22. Position statement and guidelines for the use of voice prostheses in tracheotomized persons with or without ventilatory dependence. Ad Hoc Committee on Use of Specialized Medical Speech Devices. American Speech-Language-Hearing Association.
    ASHA Suppl; 1993 Mar; 35(3 Suppl 10):17-20. PubMed ID: 8097645
    [No Abstract]   [Full Text] [Related]  

  • 23. Tailoring to fit. Altering our approach to multicultural populations.
    Goldberg B
    ASHA; 1997; 39(2):22-8. PubMed ID: 9110499
    [No Abstract]   [Full Text] [Related]  

  • 24. Credibility and credentialing. ASHA's commitment to the CCCs.
    Swigert N; Geffner D
    ASHA; 1998; 40(4):10. PubMed ID: 9796119
    [No Abstract]   [Full Text] [Related]  

  • 25. Designing a future.
    deFur LP; Kellum G
    ASHA; 1997; 39(4):12. PubMed ID: 9343874
    [No Abstract]   [Full Text] [Related]  

  • 26. Kindred spirits: finding then in ASHA's special interest divisions.
    Goldberg B
    ASHA; 1998; 40(2):24-9. PubMed ID: 9567436
    [No Abstract]   [Full Text] [Related]  

  • 27. Better hearing and speech month goes to school.
    James EL; Karr ST
    ASHA; 1994 May; 36(5):31. PubMed ID: 8037776
    [No Abstract]   [Full Text] [Related]  

  • 28. Provision of English-as-a-second-language instruction by speech-language pathologists in school settings. ASHA Multicultural Issues Board.
    ASHA Suppl; 1998; 40(2 Suppl 18):24-7. PubMed ID: 9567447
    [No Abstract]   [Full Text] [Related]  

  • 29. Charlena M Seymour.
    Seymour CM
    ASHA; 1997; 39(1):18-23. PubMed ID: 9008986
    [No Abstract]   [Full Text] [Related]  

  • 30. Credit where credit is due.
    Vekovius GT
    ASHA; 1994 Dec; 36(12):4. PubMed ID: 7818605
    [No Abstract]   [Full Text] [Related]  

  • 31. Why specialty recognition?
    Brooks GB; Gonzalez Rothi LJ
    ASHA; 1997; 39(4):14-5. PubMed ID: 9343875
    [No Abstract]   [Full Text] [Related]  

  • 32. Social issues distract.
    Carlson M
    ASHA; 1994 Dec; 36(12):3. PubMed ID: 7818599
    [No Abstract]   [Full Text] [Related]  

  • 33. Thomas J. O'Toole. 1993 president.
    O'Toole TJ
    ASHA; 1993 Jan; 35(1):30-5. PubMed ID: 8427608
    [No Abstract]   [Full Text] [Related]  

  • 34. Federal health reform--what happened?
    Markus GR
    ASHA; 1994 Dec; 36(12):19-20. PubMed ID: 7818597
    [No Abstract]   [Full Text] [Related]  

  • 35. Private practice may be for you.
    Carey AL
    ASHA; 1992 Feb; 34(2):3-5. PubMed ID: 1558550
    [No Abstract]   [Full Text] [Related]  

  • 36. Mentoring--an enriching experience.
    Slater SC
    ASHA; 1993 May; 35(5):55. PubMed ID: 8318051
    [No Abstract]   [Full Text] [Related]  

  • 37. Three generations of ASHA members.
    Toner MA
    ASHA; 1994 Apr; 36(4):44-5. PubMed ID: 8003082
    [No Abstract]   [Full Text] [Related]  

  • 38. ASHA's corporate partners. Important and necessary.
    Dublinske S
    ASHA; 1994 Feb; 36(2):46-7. PubMed ID: 8166766
    [No Abstract]   [Full Text] [Related]  

  • 39. Social issues distract.
    Shields R
    ASHA; 1994 Dec; 36(12):3. PubMed ID: 7818600
    [No Abstract]   [Full Text] [Related]  

  • 40. Ethical issues in randomized clinical trials.
    Catt JH; Karlawish J; Logemann J
    ASHA; 1999; 41(3):45-6. PubMed ID: 10356857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.